Molecule Updates
eMediNexus Coverage from: 
Serum Levels of Meteorin-Like (Metrnl) are elevated in Patients with Newly Diagnosed T2DM.
eMediNexus,  02 April 2019
remove_red_eye 609 Views
#Diabetes and Endocrinology

0 Read Comments                

A new study published in dinvestigated the association between serum levels of Meteorin-like (Metrnl) – a novel adipomyokine that may improve glucose tolerance and affect insulin resistance, with blood glucose status and to its association with insulin resistance. This study entailed measuring of serum levels of Metrnl of the participants through enzyme-linked immunosorbent assay (ELISA). The study included 40 subjects with normal glucose tolerance (NGT); 40 with impaired fasting glucose
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!